Cotinine and nicotine inhibit each other's calcium responses in bovine chromaffin cells

Toxicology and Applied Pharmacology

Volumn 163, Issue 2, 2000, Pages 183-187

  Vainio, Petri J ^a   Törnquist, Kid ^b   Tuominen, Raimo K ^a,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Adrenal medulla; Bovine; Calcium; Cotinine; Nicotine

Indexed keywords

CHLORISONDAMINE; COTININE; HEXAMETHONIUM; NICOTINE; NIMODIPINE; TETRODOTOXIN; THAPSIGARGIN;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CHROMAFFIN CELL; CONTROLLED STUDY; EXTRACELLULAR CALCIUM; NONHUMAN;

ANIMALIA; BOVINAE;

EID: 0343851607     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1999.8863     Document Type: Article

References (35)

1. 3H]nicotine to rat brain membranes. FEBS Lett. 157:1983;147-149.
2. 3H]-nicotine in isolated rat hepatocytes and hepatocyte membranes. Arch. Int. Pharmacodyn. 273:1985;62-73.
3. Andersson K., Jansson A., Kuylenstierna F., Eneroth P. Nicotine and its major metabolite cotinine have different effects on aldosterone and prolactin serum levels in the normal male rat. Eur. J. Pharmacol. 228:1993;305-312.
4. Dollery C. Therapeutic Drugs. 1991;N65-N72 Churchill Livingstone, Edinburgh.
5. Benowitz N. L., Jacob P. III. Daily intake of nicotine during cigarette smoking. Clin. Pharmacol. Ther. 35:1984;499-504.
6. Benowitz N. L., Kuyt F., Jacob P. III, Jones R., Osman A.-L. Cotinine disposition and effects. Clin. Pharmacol. Ther. 34:1983;604-611.
7. +, agents that stimulate catecholamine secretion, in isolated adrenal chromaffin cells. J. Neurochem. 42:1984;607-617.
8. Briggs C. A., McKenna D. G. Activation and inhibition of the human α7 nicotinic acetylcholine receptor by agonists. Neuropharmacology. 37:1998;1095-1102.
9. Donnelly-Roberts D. L., Arneric S. P., Sullivan J. P. Functional modulation of human "ganglionic-like" neuronal nicotinic acetylcholine receptors (nAChRs) by l-type calcium channel anatgonists. Biochem. Biophys. Res. Commun. 213:1995;657-662.
10. Eberhard D. A., Holz R. W. Cholinergic stimulation of inositol phosphate formation in bovine adrenal chromaffin cells: distinct nicotinic and muscarinic mechanisms. J. Neurochem. 49:1987;1634-1643.
11. Erenmemisoglu A., Tekol Y. Do nicotine metabolites have an effect on pain perception? Antinociceptive effect of cotinine in mice. Pharmazie. 49:1994;374-375.
12. Feyerabend C., Ings R. M. J., Russel M. A. H. Nicotine pharmacokinetics and its application to intake from smoking. Br. J. Clin. Pharmacol. 19:1985;239-247.
13. Frye R. A., Holz R. W. The relationship between arachidonic acid release and catecholamine secretion from cultured bovine adrenal chromaffin cells. J. Neurochem. 43:1984;146-150.
14. Fuxe K., Everitt B. J., Hökfelt T. On the action of nicotine and cotinine on central 5-hydroxytryptamine neurons. Pharmacol. Biochem. Behav. 10:1979;671-677.
15. Gandia L., Casado L., López M. G., Garcia A. G. Separation of two pathways for calcium entry into chromaffin cells. Br. J. Pharmacol. 103:1991;1073-1078.
16. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440-3450.
17. Hatsukami D., Lexau B., Nelson D., Pentel P. R., Sofuoglu M., Goldman A. Effects of cotinine on cigarette self-administration. Psychopharmacology. 138:1998a;184-189.
18. Hatsukami D., Pentel P. R., Jensen J., Nelson D., Allen S. S., Goldman A., Rafael D. Cotinine: Effects with and without nicotine. Psychopharmacology. 135:1998b;141-150.
19. 2+ uptake and catecholamine secretion in primary dissociated cultures of adrenal medulla. J. Neurochem. 39:1982;635-646.
20. Hurt R. D., Dale L. C., Offord K. P., Lauger G. G., Baskin L. B., Lawson G. M., Jiang N. S., Hauri P. J. Serum nicotine and cotinine levels during nicotine-patch therapy. Clin. Pharmacol. Ther. 54:1993;98-106.
21. Keenan R. M., Hatsukami D. K., Pentel P. R., Thompson T. N., Grillo M. A. Pharmacodynamic effects of cotinine in abstinent cigarette smokers. Clin. Pharmacol. Ther. 55:1994;581-590.
22. Kilpatrick D. L., Slepetis R., Kirshner N. Ion channels and membrane potential in stimulus-secretion coupling in adrenal medulla cells. J. Neurochem. 36:1981;1245-1255.
23. Kim K. S., Borzelleca J. F., Bowman E. R., McKennis H. Jr. Effects of some nicotine metabolites and related compounds on isolated smooth muscle. J. Pharmacol. Exp. Ther. 161:1968;59-69.
24. Kyerematen G. A., Taylor L. H., deBethizy J. D., Vesell E. S. Pharmacokinetics of nicotine and 12 metabolites in the rat. Application of a new radiometric high performance liquid chromatography assay. Drug Metab. Dispos. 16:1988;125-129.
25. + efflux from mouse thalamic synaptosomes. J. Pharmacol. Exp. Ther. 277:1996;1383-1396.
26. Marley P. D. Desensitization of the nicotinic secretory response of adrenal chromaffin cells. Trends Pharmacol. Sci. 9:1988;102-107.
27. McMillian M. K., Tuominen R. K., Hudson P. M., Suh H. H., Hong J. S. Angiotensin II receptors are coupled to ω-conotoxin-sensitive calcium influx in bovine adrenal medullary chromaffin cells. J. Neurochem. 58:1992;1285-1291.
28. Sastry B. V. R., Chance M. B., Singh G., Horn J. L., Janson V. E. Distribution and retention of nicotine and its metabolite, cotinine, in the rat as a function of time. Pharmacology. 50:1995;128-136.
29. Törnquist K. Evidence for receptor-mediated calcium entry and refilling of intracellular calcium stores in FRTL-5 rat thyroid cells. J. Cell. Physiol. 150:1992;90-98.
30. Vainio P. J., Viluksela M., Tuominen R. K. Inhibition of nicotinic responses by cotinine in bovine adrenal chromaffin cells. Pharmacol. Toxicol. 83:1998a;188-193.
31. Vainio P. J., Viluksela M., Tuominen R. K. Nicotine-like effects of cotinine on protein kinase C activity and noradrenaline release in bovine adrenal chromaffin cells. J. Auton. Pharmacol. 18:1998b;245-250.
32. Wilson S. P. Purification of adrenal chromaffin cells on Renografin gradients. J. Neurosci. Methods. 19:1987;163-171.
33. Xiao Y., Meyer E. L., Thompson J. M., Surin A., Wroblewski J., Kellar K. J. Rat α3/β4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: Pharmacology of ligand binding and function. Mol. Pharmacol. 54:1998;322-333.
34. Zevin S., Jacob P. I., Benowitz N. L. Cotinine effects on nicotine metabolism. Clin. Pharmacol. Ther. 61:1997;649-654.
35. Zhou Z., Neher E. Calcium permeability of nicotinic acetylcholine receptor channels in bovine adrenal chromaffin cells. Pflügers Archiv. 425:1993;511-517.